Dr. Tarek El-Sawy, MD

Dr. El-Sawy practices at Spectrum Eye Physicians, a Medical Corporation in Cupertino, California.

Dr. El-Sawy's NPI, 1922269083, was assigned on June 21, 2008. Dr. El-Sawy graduated from Cleveland Medical College, Homeopathic in 2006. Dr. El-Sawy's California license number on file is A120920.

Dr. El-Sawy's primary practice is Spectrum Eye Physicians, a Medical Corporation, at 10300 S De Anza Blvd, Cupertino, CA 95014 in Santa Clara County. The practice phone is (408) 253-3083.

Dr. El-Sawy's primary practice is Spectrum Eye Physicians, a Medical Corporation in Cupertino, California. Dmand AI also links Dr. El-Sawy to 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. El-Sawy practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. El-Sawy's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. El-Sawy is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. El-Sawy's licenses on file in 3 states: California, Texas and New York.

Dmand AI lists cataract, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation, glaucoma, hypertensive retinopathy and inflammation of iris among the conditions Dr. El-Sawy treats.

CMS data shows 8,441 Medicare services from Dr. El-Sawy across 19 procedure codes in 2024, for 706 Medicare patients. Medicare paid $402,648 for them.

CMS counts 706 Medicare patients who saw Dr. El-Sawy in 2024. The largest group is 75 to 84, with 304 patients. 75% of them have high cholesterol, and 64% have high blood pressure. 10% are also on Medicaid. Their average risk score is 0.95, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. El-Sawy's median patient age at 71, with 61% women.

In 2024, Dr. El-Sawy wrote 672 Medicare Part D claims for 415 patients. 93% of them were for generic drugs. CMS names the drug for 592 of them, across 5 drugs with 11 or more claims each, at $5,460 in total drug cost. In 2023, CMS named 576 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. El-Sawy for performance year 2024, reported as part of a group. Dr. El-Sawy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 19 procedures of melanoma (skin cancer) excision by Dr. El-Sawy, more than 74% of the clinicians it reports for that procedure.

Dmand AI links 23 papers to Dr. El-Sawy, published from 2011 to 2020. 2014 was the busiest year, with 2. The most frequent topics are Genetic Vectors, Gene Transfer Techniques and Disease Models, Animal. Dr. El-Sawy has published most often in Ophthalmic Plast Reconstr Surg. Dr. El-Sawy's most frequent co-authors are Bita Esmaeli, MD, Ronald G. Crystal, MD and Leonard Young Lee, MD.

CMS Open Payments shows 37 general payments to Dr. El-Sawy from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 60% of the total. Seagen Inc. paid the most, $1,680.

Dmand AI lists 1 award for Dr. El-Sawy, most recently CMS Stage 1 EHR in 2013.

Dr. El-Sawy graduated from Cleveland Medical College, Homeopathic in 2006.

Dr. El-Sawy is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.